The global particle therapy market size is expected to reach USD 2.2 billion by 2027 at a CAGR of 11.50% during the forecast period from 2020-2027. Increasing cancer patient pool, advantages provided by particle therapy over photon therapy, and demand of minimally invasive therapy are some of the major growth drivers.
Particle therapy is a technique which uses rays of charged positive ions, neutrons, or protons for cancer treatment. It is an external beam radiotherapy. It combines research in physics and its application in the field of oncology. The non-invasive characteristic of particle therapy serves as a major advantage that for the treatment of cancer. Carbon ion beams are used in the treatment of cancer. Proton therapy is one of the most used type of particle therapy. It uses proton beams to irradiate affected tissue. Proton therapy employs ionizing radiation, in which a particle accelerator is used to aim tumors with proton beams.
Increasing demand for better minimally invasive therapies for cancer treatment and increasing government funding to set up these equipment in hospitals in developing countries are positively impacting the market. In addition, rising awareness regarding particle therapy and increasing investments by major players are expected to strengthen the market. High cost of the treatment and lack of skilled professionals may restrict the growth of the market. However, increasing number of medical professionals and patients opting for particle therapy are expected to drive the market.
On the geographical standpoint, North America and Europe are projected to dominate the global particle therapy market, attributable to an expansion in the interest for proficient and powerful administration of particle therapy and high rate of reception of particle therapy for treatment arranging by oncologist. The market in Asia Pacific is anticipated to extend at an exponential development rate during the conjecture time frame. This is ascribed to an enormous base of claim to fame facilities and medical clinics, ascend in the geriatric populace with cerebrum and spine tumor sicknesses requiring particle therapy administrations, and increment in the rate of appropriation of new treatments, for example, carbon and particle therapy for the treatment of malignant growth patients. The market for particle therapy in Latin America is probably going to extend at a moderate development rate during the figure time frame.
Improving Quality of Particle Therapy Drives the Market Growth
The global particle therapy market is anticipated to be possibly determined by the highlights and qualities of particle therapy. Particle therapy is being offered by different particle therapy delivering organizations so as to streamline everyday work process and increment the income of the practices. Particle therapy gives differing highlights and advantages, going from patient agony behaving solutions for treatment methodology. These highlights help doctors and medical attendants to streamline the tumor treatment therapy action required for patients so as to keep up their day by day work process productively and adequately. The key players offering the particle therapy are presenting worth included highlights, for example, set up labs with administrations, for example, cyclotrons, synchrotrons, powerful methodology highlights, alongside imaging modules, accordingly decreasing the general working expense and subsequently, improving the general adequacy and proficiency of particle therapy rehearses. Organizations are concentrating on the advancement of joined particle and carbon therapy offices in their framework so as to adequately coordinate the therapy or treatment technique and patient instruction and mindfulness programs on particle therapy. These worth included highlights spare the operational time of doctors and help improve its agony the executives execution among malignancy patients.
Cyclotrons in anticipated to be very worthwhile portion for administrations
Cyclotrons are non-reactor sources that are utilized to create different radioisotopes or electrons or particles. High vitality utilization and breaking down apparatus produce half-life radioisotopes or particles that are used in the treatment of various kinds of malignant growth. Cyclotrons empower the client to practice low recurrence clinical applications, along these lines permitting the mending of outrageous instances of tumor deterioration, which thusly is probably going to move the section during the estimate time frame. The act of atomic drug in Middle East and Asia has been growing essentially over the most recent couple of years. For example, most cyclotrons introduced in India are somewhere in the range of 12 and 18 MeV and just few of 30 MeV; nearly most cyclotrons introduced in Japan are somewhere in the range of 12 and 18 MeV just as 30 MeV.
Key players operating in the market are include Varian Medical Systems, Inc., on Beam Applications SA, Provision Healthcare, Hitachi, Ltd., Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy plc, Danfysik A/S, ProTom International, Inc., and among others. Key players active in the market are involved in collaborative agreements and expansion to bolster the growth of the market.
The global particle therapy market has been segmented as given below:
Global Particle Therapy Market, by Therapy
Global Particle Therapy Market, by Cancer Application
Global Particle Therapy Market, by Services
Global Particle Therapy Market, by End-user
Global Particle Therapy Market, by Region
The report analyzes and forecasts the particle therapy market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global particle therapy market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the particle therapy market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of particle therapy market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Reasons to Purchase this Report:
- Estimates 2019-2026 particle therapy market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...
Optical Imaging Systems Market (By Technology: Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy; By Product: Imaging Systems, Optical Imaging Software, Illumination Systems, Others; By Application: Pathological, Intraoperative; By End-use Outlook; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...